CAS 1185053-50-2

Clozapine-d8

CAS : 1185053-50-2

Clozapine-d8

Degré de pureté : ≥95%

Masse moléculaire : 334.87g/mol

Ref: 54-DE2201

Clozapine-d8

CAS : 1185053-50-2

Formule : C₁₈H₁₁D₈ClN₄

Masse moléculaire : 334.88

Ref: 4Z-C-1421

Clozapine-d8

CAS : 1185053-50-2

Clozapine-d8 is a deuterium-labeled analog of Clozapine, used as an internal standard for mass spectrometric analysis of this atypical antipsychotic.

Formule : C₁₈H₁₉ClN₄

Couleur et forme : Solid

Masse moléculaire : 334.87

Ref: TM-TMIH-0166

Clozapine-d8

Produit contrôlé

CAS : 1185053-50-2

Applications An antipsychotic.A representative lot was 92% d8, 8% d7.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Stille, et al: Farnaco, Ed. Prat., 26, 603 (1971), Hane, J.M., et al.: Psychopharmacol. Bull., 24, 62 (1988), Meltzer, H.Y.: J. Clin. Psychiatry, 55, Suppl. B, 47 (1994)

Formule : C₁₈H₁₁D₈ClN₄

Couleur et forme : Light Yellow To Yellow

Masse moléculaire : 334.87

Ref: TR-C587502

Clozapine-d8

Produit contrôlé

CAS : 1185053-50-2

Clozapine-d8 is a medicinal analog that has been shown to have potent anticancer properties. This compound is a kinase inhibitor that targets proteins involved in cell growth and division, leading to apoptosis (programmed cell death) in cancer cells. Clozapine-d8 has been tested on human cancer cells and has been found to be effective against a variety of tumor types. In addition, this compound is excreted in urine, making it an attractive candidate for non-invasive diagnostic testing. The use of Clozapine-d8 as an inhibitor of kinases involved in cancer progression holds great promise for the development of novel anticancer therapies.

Formule : C₁₈H₁₉ClN₄

Degré de pureté : Min. 95%

Masse moléculaire : 334.9 g/mol

Ref: 3D-KXB05350